MarketPeel
Insider Trading Intelligence
ST

Stephen Basil Thomas

CLYM
DIRECTOR · CLIMB BIO, INC. · CIK 0002027962
FILING MIX · LIFETIME46%/54%
BUYS
6
SELLS
7
TOTAL VALUE
$879.4K
COMPANIES
1
ACTIVE SINCE
Jan 2025
HOLDINGS NOW
40,000
AVG SELL PX
$5.86
TRADE KIND
SHOWING 13 / 13
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 12 pending
Forward-return performance of every backtestable P/S trade by Stephen Basil Thomas, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+25.00%+2.25%-0.18%+2.43%+2.50%
14d4+25.00%+16.99%-1.00%+17.99%+15.65%
30d4+50.00%+13.29%-5.29%+18.58%+17.57%
60d4+0.00%+45.60%+2.38%+43.22%+42.52%
90d4+0.00%+82.20%+8.92%+100.74%+100.74%
180d4(4 pending)
1y4(4 pending)
2y4(4 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CLYM · 40,000 shares · as of Jun 5, 2026
076,164152,329228,493304,65720252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2025
2025
2025
2025
2026
2026
FLOW · 6 buys / 7 sellsCOVERAGE · 6 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CLYM
CLIMB BIO, INC.
PURCHASEGRANT
Stock grant
40,00040,000Jun 5, 2026Jun 8, 2026View →
CLYM
CLIMB BIO, INC.
SALE10b5-1
10b5-1 plan
16,313$7.01$114.3K154,657Feb 26, 2026Feb 27, 2026View →
CLYM
CLIMB BIO, INC.
SALE10b5-1
10b5-1 plan
33,687$7.00$236.0K170,970Feb 25, 2026Feb 27, 2026View →
CLYM
CLIMB BIO, INC.
SALE10b5-1
10b5-1 plan
10,000$5.81$58.1K204,657Feb 13, 2026Feb 17, 2026View →
CLYM
CLIMB BIO, INC.
SALE10b5-1
10b5-1 plan
90,000$5.23$471.0K214,657Feb 12, 2026Feb 17, 2026View →
CLYM
CLIMB BIO, INC.
PURCHASEGRANT
Stock grant
100,375304,657Aug 7, 2025Aug 11, 2025View →
CLYM
CLIMB BIO, INC.
PURCHASE
25,094204,282Jun 27, 2025Jul 1, 2025View →
CLYM
CLIMB BIO, INC.
SALE
25,0940Jun 27, 2025Jul 1, 2025View →
CLYM
CLIMB BIO, INC.
PURCHASEGRANT
Stock grant
40,00040,000Jun 4, 2025Jun 5, 2025View →
CLYM
CLIMB BIO, INC.
PURCHASE
25,093179,188Mar 27, 2025Mar 27, 2025View →
CLYM
CLIMB BIO, INC.
SALE
25,09325,094Mar 27, 2025Mar 27, 2025View →
CLYM
CLIMB BIO, INC.
PURCHASE
50,188154,095Jan 1, 2025Jan 3, 2025View →
CLYM
CLIMB BIO, INC.
SALE
50,18850,187Jan 1, 2025Jan 3, 2025View →
Other insiders · CLYM
Loading peer insiders…
About this filer
CIK 0002027962
ROLE
Director
PRIMARY
CLYM
COMPANIES
1
ACTIVE SINCE
Jan 2025
MARKETPEEL · /INSIDER/0002027962DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback